[Bilateral hydronephrosis as a result of opioid-induced bowel spasm in a patient with an ileal conduit]

F Girtler1, K Rödder2, M Fisch3

  • 1Belegabteilung für Urologie, Krankenhaus Buchholz i.d.N., Steinbecker Str. 44, 21244, Buchholz i.d.N., Deutschland. fabian.girtler@gmx.de.

Insights

Opioid therapy can cause bowel spasms leading to urinary obstruction in patients with ileal conduits. Reducing opioid dosage resolved hydronephrosis, suggesting this was the cause.

Area of Science:

  • Urology
  • Nephrology
  • Pharmacology

Background:

  • A 47-year-old woman with a history of spina bifida and ileal conduit presented with symptoms suggestive of ureteral reimplantation site stenosis.
  • Her medical history included recent escalation of opioid medication for neuropathic pain management.

Observation:

  • The patient experienced left flank pain, bilateral hydronephrosis, and oliguria.
  • Initial assessment suggested recurrent stenosis at the ureteral implantation site, with percutaneous nephrostomy placement and discussion of open ureteral reimplantation.

Findings:

  • Following a reduction in opioid dosage, the patient's hydronephrosis resolved.
  • This clinical course indicated that opioid-induced bowel spasm was the likely cause of the urinary obstruction, rather than anatomical stenosis.

Implications:

  • This case highlights the importance of considering medication side effects, specifically opioid-induced bowel spasm, in the differential diagnosis of urinary obstruction in patients with ileal conduits.
  • Conservative management, such as medication adjustment, may obviate the need for surgical intervention in select cases.
  • Further research into the mechanisms and prevalence of opioid-induced gastrointestinal and urinary complications is warranted.

Related Concept Videos

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
843
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
824
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
854
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
895
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
410